350 related articles for article (PubMed ID: 24729399)
1. BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis.
Ntatsaki E; Carruthers D; Chakravarty K; D'Cruz D; Harper L; Jayne D; Luqmani R; Mills J; Mooney J; Venning M; Watts RA;
Rheumatology (Oxford); 2014 Dec; 53(12):2306-9. PubMed ID: 24729399
[No Abstract] [Full Text] [Related]
2. Rituximab or cyclophosphamide in ANCA-associated renal vasculitis.
Karassa FB
N Engl J Med; 2010 Nov; 363(21):2073; author reply 2073-4. PubMed ID: 21083398
[No Abstract] [Full Text] [Related]
3. [Rituximab to treat ANCA-associated vasculitis].
Guillevin L; Mahr A
Rev Med Interne; 2011 Oct; 32(10):591-3. PubMed ID: 21872370
[No Abstract] [Full Text] [Related]
4. L52. Vasculitis treatment: is it time to change the standard of care for ANCA-associated vasculitis?
Hoffman GS
Presse Med; 2013 Apr; 42(4 Pt 2):643-50. PubMed ID: 23474045
[No Abstract] [Full Text] [Related]
5. Rituximab or cyclophosphamide in ANCA-associated renal vasculitis.
Nossent JC
N Engl J Med; 2010 Nov; 363(21):2072; author reply 2073-4. PubMed ID: 21083400
[No Abstract] [Full Text] [Related]
6. Rituximab or cyclophosphamide in ANCA-associated renal vasculitis.
Hebert LA; Ardoin S; Shim RL
N Engl J Med; 2010 Nov; 363(21):2072-3; author reply 2073-4. PubMed ID: 21083399
[No Abstract] [Full Text] [Related]
7. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis.
Rich EN; Brown KK
Curr Opin Pulm Med; 2012 Sep; 18(5):447-54. PubMed ID: 22854508
[TBL] [Abstract][Full Text] [Related]
8. Rituximab or cyclophosphamide in ANCA-associated renal vasculitis.
Schönermarck U; Rau S; Fischereder M
N Engl J Med; 2010 Nov; 363(21):2072; author reply 2073-4. PubMed ID: 21083401
[No Abstract] [Full Text] [Related]
9. L44. Management of relapses in vasculitis.
Mouthon L
Presse Med; 2013 Apr; 42(4 Pt 2):619-22. PubMed ID: 23477710
[No Abstract] [Full Text] [Related]
10. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.
Lapraik C; Watts R; Bacon P; Carruthers D; Chakravarty K; D'Cruz D; Guillevin L; Harper L; Jayne D; Luqmani R; Mooney J; Scott D;
Rheumatology (Oxford); 2007 Oct; 46(10):1615-6. PubMed ID: 17804455
[No Abstract] [Full Text] [Related]
11. Rituximab in ANCA-associated disease.
Falk RJ; Jennette JC
N Engl J Med; 2010 Jul; 363(3):285-6. PubMed ID: 20647204
[No Abstract] [Full Text] [Related]
12. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
Jones RB; Furuta S; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh M; Westman K; Jayne DR;
Ann Rheum Dis; 2015 Jun; 74(6):1178-82. PubMed ID: 25739829
[TBL] [Abstract][Full Text] [Related]
13. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.
Jones RB; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh D; Walsh M; Westman K; Jayne DR;
N Engl J Med; 2010 Jul; 363(3):211-20. PubMed ID: 20647198
[TBL] [Abstract][Full Text] [Related]
14. [Rituximab for the treatment of ANCA associated vasculitis: the future today?].
Alba MA; Flores-Suárez LF
Reumatol Clin; 2011 Dec; 7 Suppl 3():S41-6. PubMed ID: 22115869
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of ANCA-associated vasculitis ... 40 years later].
Arazzi M
G Ital Nefrol; 2013; 30(5):. PubMed ID: 24941484
[No Abstract] [Full Text] [Related]
16. S2. Rituximab for ANCA-associated vasculitis: the UK experience.
Jayne D
Presse Med; 2013 Apr; 42(4 Pt 2):532-4. PubMed ID: 23490639
[No Abstract] [Full Text] [Related]
17. Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.
Guerry MJ; Brogan P; Bruce IN; D'Cruz DP; Harper L; Luqmani R; Pusey CD; Salama AD; Scott DG; Savage CO; Watts RA; Jayne DR
Rheumatology (Oxford); 2012 Apr; 51(4):634-43. PubMed ID: 21613248
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of vasculitis].
Novak S
Reumatizam; 2013; 60(2):47-54. PubMed ID: 24979997
[TBL] [Abstract][Full Text] [Related]
19. Refractory disease in antineutrophil cytoplasmic antibodies associated vasculitis.
Rutgers A; Kallenberg CG
Curr Opin Rheumatol; 2012 May; 24(3):245-51. PubMed ID: 22410545
[TBL] [Abstract][Full Text] [Related]
20. [ANCA-associated vasculitis].
Holle JU
Internist (Berl); 2015 Jan; 56(1):41-50; quiz 51-2. PubMed ID: 25502657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
